Johnson & Johnson Vision has announced the U.S. Food and Drug Administration (FDA) has approved the TECNIS EyhanceTM and TECNIS EyhanceTM Toric II intraocular lens (IOL) for the treatment of cataract patients in the United States. With this approval and subsequent commercial launch, ophthalmologists in the U.S. now have the ability to choose this next generation monofocal as the lens of choice for their patients with or without astigmatism. The first implantation of TECNIS Eyhance IOL in the U.S. will happen in Texas next week.
The latest innovation in the TECNIS® Family of IOLs - TECNIS Eyhance and TECNIS Eyhance Toric II IOLs – is defining the future of monofocals, with a breakthrough refractive surface designed to:
-
Slightly extend the depth of focus1* through the unique shape of the lens
-
Deliver better image contrast in low light9 TECNIS Eyhance IOLs deliver 30% improvement in image contrast compared to AcrySof IQ SN60WF at 5mm
-
Provide safe and easy delivery using the new TECNIS Simplicity® system that streamlines lens delivery and protects against contamination10
The TECNIS Eyhance IOL is the latest lens in the TECNIS Family, which celebrates its 20th anniversary this year. The TECNIS Family portfolio is the broadest mix of IOLs for cataract patients in need of monofocals, multifocals, extended depth of focus (EDOF), and those with or without astigmatism.
“Built on the proven TECNIS® platform, TECNIS Eyhance combines low-light performance with breakthrough refractive surface design, providing a new kind of monofocal experience for cataract patients,” said Rajesh K. Rajpal, MD, Chief Medical Officer and Global Head of Clinical and Medical Affairs at Johnson & Johnson Vision. “Additionally, the TECNIS Eyhance Toric II lens is engineered with a new squared and frosted haptic design for added friction inside the capsular bag to treat cataract patients with astigmatism.”
TECNIS Eyhance first launched in Europe in February 2019 and became commercially available in Latin America and Canada in the summer of 2020. TECNIS Eyhance and TECNIS Eyhance Toric II are now commercially available in the U.S., with TECNIS Eyhance Toric II launching in Europe and Canada later this year.
Full press release: www.jjvision.com/press-release/johnson-johnson-vision-receives-fda-approval-next-generation-monofocal-intraocular
Source: Johnson & Johnson Vision